ATE392419T1 - Androgenmodulatoren - Google Patents

Androgenmodulatoren

Info

Publication number
ATE392419T1
ATE392419T1 AT05779469T AT05779469T ATE392419T1 AT E392419 T1 ATE392419 T1 AT E392419T1 AT 05779469 T AT05779469 T AT 05779469T AT 05779469 T AT05779469 T AT 05779469T AT E392419 T1 ATE392419 T1 AT E392419T1
Authority
AT
Austria
Prior art keywords
directed
androgen modulators
modulators
androgen
benzonitriles
Prior art date
Application number
AT05779469T
Other languages
English (en)
Inventor
Stephen Douglas Barrett
Daniel Yunlong Du
Lain-Yen Hu
Bruce Allen Lefker
Raj Kumar Raheja
Karen Elaine Sexton
Yvonne Dorothy Smith
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE392419T1 publication Critical patent/ATE392419T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Furan Compounds (AREA)
AT05779469T 2004-08-31 2005-08-22 Androgenmodulatoren ATE392419T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60589604P 2004-08-31 2004-08-31

Publications (1)

Publication Number Publication Date
ATE392419T1 true ATE392419T1 (de) 2008-05-15

Family

ID=35453498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05779469T ATE392419T1 (de) 2004-08-31 2005-08-22 Androgenmodulatoren

Country Status (15)

Country Link
US (1) US20070207987A1 (de)
EP (1) EP1789408B1 (de)
JP (1) JP2008511606A (de)
KR (1) KR20070049238A (de)
CN (1) CN101044131A (de)
AT (1) ATE392419T1 (de)
AU (1) AU2005278892A1 (de)
BR (1) BRPI0514706A (de)
CA (1) CA2578194A1 (de)
DE (1) DE602005006139T2 (de)
ES (1) ES2302229T3 (de)
IL (1) IL181447A0 (de)
MX (1) MX2007002377A (de)
NO (1) NO20070953L (de)
WO (1) WO2006024942A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2554696C (en) 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
WO2005100305A1 (en) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
JP2007533726A (ja) 2004-04-22 2007-11-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター
MXPA06015169A (es) 2004-07-08 2007-08-21 Warner Lambert Co Moduladores de androgenos.
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3164523A (en) * 1961-03-22 1965-01-05 Warner Lambert Pharmaceutical Composition for skin beautification and treatment
DE10218963A1 (de) * 2002-04-27 2003-11-20 Aventis Pharma Gmbh Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen
EP1687274A1 (de) * 2003-11-20 2006-08-09 Warner-Lambert Company LLC Modulatoren des androgenrezeptors
CA2554696C (en) * 2004-02-13 2009-06-30 Warner-Lambert Company Llc Androgen receptor modulators
WO2005100305A1 (en) * 2004-04-13 2005-10-27 Warner-Lambert Company Llc Androgen modulators
JP2007533726A (ja) * 2004-04-22 2007-11-22 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー アンドロゲンモジュレーター

Also Published As

Publication number Publication date
EP1789408A1 (de) 2007-05-30
DE602005006139D1 (de) 2008-05-29
BRPI0514706A (pt) 2008-06-24
KR20070049238A (ko) 2007-05-10
CA2578194A1 (en) 2006-03-09
AU2005278892A1 (en) 2006-03-09
WO2006024942A1 (en) 2006-03-09
EP1789408B1 (de) 2008-04-16
NO20070953L (no) 2007-03-20
DE602005006139T2 (de) 2009-05-07
IL181447A0 (en) 2007-07-04
CN101044131A (zh) 2007-09-26
JP2008511606A (ja) 2008-04-17
ES2302229T3 (es) 2008-07-01
MX2007002377A (es) 2007-04-23
US20070207987A1 (en) 2007-09-06

Similar Documents

Publication Publication Date Title
TW200605876A (en) Androgen modulators
MX2007001993A (es) Moduladores de androgenos.
EA200602221A1 (ru) Новое применение пептидных соединений для лечения боли при тригеминальной невралгии
NO20063064L (no) Ny anvendelse av peptidforbindelser for behandling av sentralneurotisk smerte
CR9647A (es) Moduladores de cinasa de aminoquinolina y amoniquinazolina
UA104677C2 (ru) Производные мочевины и их терапевтическое применение при лечении, среди прочего, заболеваний дыхательных путей
DE60234873D1 (de) Verwendung von COX-2 Inhibitoren zur Behandlung von affectiven Störungen
CR9652A (es) Moduladores de alquilquinolina y alquilquinazolina cinasa
EA200700702A1 (ru) Аналоги локсапина и способы их применения
FR2916633B1 (fr) Utilisation cosmetique d'un actif capable de stimuler l'expression de la tensine 1
NO20070953L (no) Androgenmodulatorer
GEP20094843B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
BRPI0822843A2 (pt) "dispositivo portátil para tratamento de cabelo para estimulação de crescimento do cabelo no couro cabeludo"
SE0401465D0 (sv) New substituted piperdines as modulators of dopamine neurotransmission
CR9496A (es) Moduladores de androgenos
EA200601267A1 (ru) Модуляторы рецепторов андрогена
WO2007017754A3 (en) Androgen modulators
CA2562672A1 (en) 4-cyano-phenoxy derivatives as androgen modulators
DE602004022935D1 (de) Verbesserungen des stimulationserfolgs-managements
BRPI0509759A (pt) moduladores de androgênio
DK1562547T3 (da) Fremgangsmåde til at stimulere hårvækst under anvendelse af benzopyraner
DE60235889D1 (de) Reduktion des haarwachstums
ATE376416T1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
ITFI20050225A1 (it) Manipolo applicatore per sutura-laser indotta della cornea
DOP2005000129A (es) Moduladores de androgenos